Therapeutic Silencing of Bcl-2 by Systemically Administered siRNA Nanotherapeutics Inhibits Tumor Growth by Autophagy and Apoptosis and Enhances the Efficacy of Chemotherapy in Orthotopic Xenograft Models of ER (-) and ER (+) Breast Cancer (Q33637380)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Therapeutic Silencing of Bcl-2 by Systemically Administered siRNA Nanotherapeutics Inhibits Tumor Growth by Autophagy and Apoptosis and Enhances the Efficacy of Chemotherapy in Orthotopic Xenograft Models of ER (-) and ER (+) Breast Cancer |
scientific article |
Statements
1 reference
Therapeutic Silencing of Bcl-2 by Systemically Administered siRNA Nanotherapeutics Inhibits Tumor Growth by Autophagy and Apoptosis and Enhances the Efficacy of Chemotherapy in Orthotopic Xenograft Models of ER (-) and ER (+) Breast Cancer (English)
1 reference
Anil K Sood
1 reference
Ibrahim Tekedereli
1 reference
S Neslihan Alpay
1 reference
Ugur Akar
1 reference
Erkan Yuca
1 reference
Cristian Ayugo-Rodriguez
1 reference
He-Dong Han
1 reference
Gabriel Lopez-Berestein
1 reference
Bulent Ozpolat
1 reference
10 September 2013
1 reference
1 reference
e121
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference